Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blinded, placebo-controlled trial of oral Cyclosporine A (CsA)
in patients with advanced stage chronic obstructive pulmonary disease. The purpose of the
study is to evaluate the safety and effectiveness of CsA as a therapy for the adaptive immune
response in advanced stage Chronic Obstructive Pulmonary Disease (COPD).
Subjects between 45 and 80 years of age with a confirmed diagnosis of advanced stage COPD,
not responsive to conventional inhaler therapy, who meet all the study requirements, will be
enrolled in this study. A total of 30 subjects of either sex will be enrolled in this study.